These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15097240)

  • 1. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke.
    Nazir FS; Overell JR; Bolster A; Hilditch TE; Reid JL; Lees KR
    J Hypertens; 2004 May; 22(5):989-95. PubMed ID: 15097240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial.
    Nazir FS; Overell JR; Bolster A; Hilditch TE; Lees KR
    Cerebrovasc Dis; 2005; 19(2):77-83. PubMed ID: 15608430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease.
    Walters MR; Bolster A; Dyker AG; Lees KR
    Stroke; 2001 Feb; 32(2):473-8. PubMed ID: 11157185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic cerebral autoregulation is compromised acutely following mild ischaemic stroke but not transient ischaemic attack.
    Atkins ER; Brodie FG; Rafelt SE; Panerai RB; Robinson TG
    Cerebrovasc Dis; 2010 Feb; 29(3):228-35. PubMed ID: 20029195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic influences of losartan on the brain in hypertensive patients.
    Oku N; Kitagawa K; Imaizumi M; Takasawa M; Piao R; Kimura Y; Kajimoto K; Matsumoto M; Hori M; Hatazawa J
    Hypertens Res; 2005 Jan; 28(1):43-9. PubMed ID: 15969254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke.
    Moriwaki H; Uno H; Nagakane Y; Hayashida K; Miyashita K; Naritomi H
    J Hum Hypertens; 2004 Oct; 18(10):693-9. PubMed ID: 15129230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
    Wang X; Aukland K; Iversen BM
    Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial.
    Hong KS; Kang DW; Bae HJ; Kim YK; Han MK; Park JM; Rha JH; Lee YS; Koo JS; Cho YJ; Kwon SU; Kim SE; Park SH
    Acta Neurol Scand; 2010 Jan; 121(1):51-7. PubMed ID: 19925528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
    Gansevoort RT; de Zeeuw D; Shahinfar S; Redfield A; de Jong PE
    J Hypertens Suppl; 1994 Jul; 12(2):S37-42. PubMed ID: 7965264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term losartan administration on renal haemodynamics and function in hypertensive patients.
    Paterna S; Parrinello G; Scaglione R; Costa R; Bova A; Palumbo VA; Pinto A; Amato P; Licata G
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):529-32. PubMed ID: 11101201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II.
    Miller JA; Thai K; Scholey JW
    Kidney Int; 1999 Dec; 56(6):2173-80. PubMed ID: 10594793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.
    Scaglione R; Argano C; Corrao S; Di Chiara T; Licata A; Licata G
    J Hypertens; 2005 Mar; 23(3):657-64. PubMed ID: 15716710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral perfusion in hypertensive patients: effects of lacidipine and hydrochlorothiazide.
    Semplicini A; Maresca A; Simonella C; Carollo C; Chierichetti F; Santipolo N; Pauletto P; Ferlin G; Pessina AC
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S13-8. PubMed ID: 11347856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.